AI-Powered urine test could revolutionize cervical cancer screening in Low-Income countries

NCT ID NCT06042543

Recruiting now Diagnosis Sponsor: International Agency for Research on Cancer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new, affordable AI system to screen for cervical cancer in low- and middle-income countries. The AI analyzes urine samples and cervical images to detect high-risk HPV and precancerous changes. About 3,200 unscreened women aged 25-49 in Zimbabwe will take part. The goal is to see if this one-stop approach can accurately identify women who need treatment, helping to eliminate cervical cancer worldwide.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical intraepithelial neoplasia grade 2/3 Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER SCREENING

Contacts and locations

Locations

University of Cincinnati
RECRUITING

Cincinnati, Ohio, 45221, United States
University of Zimbabwe
RECRUITING

Harare, 0002, Zimbabwe

More trials for these conditions

Other studies related to the condition(s) this trial covers.